CELLA, CHIARA ALESSANDRA
 Distribuzione geografica
Continente #
NA - Nord America 1.524
AS - Asia 607
EU - Europa 343
SA - Sud America 127
AF - Africa 16
OC - Oceania 3
Totale 2.620
Nazione #
US - Stati Uniti d'America 1.493
SG - Singapore 241
CN - Cina 148
BR - Brasile 106
HK - Hong Kong 91
UA - Ucraina 54
VN - Vietnam 47
DE - Germania 46
FR - Francia 40
GB - Regno Unito 39
RU - Federazione Russa 31
FI - Finlandia 30
IE - Irlanda 27
TR - Turchia 25
IT - Italia 24
CA - Canada 15
IN - India 15
ES - Italia 13
MX - Messico 13
AR - Argentina 10
PL - Polonia 9
SE - Svezia 9
BD - Bangladesh 8
JP - Giappone 8
ZA - Sudafrica 7
AT - Austria 5
LT - Lituania 4
PK - Pakistan 4
BE - Belgio 3
EC - Ecuador 3
IQ - Iraq 3
JO - Giordania 3
KE - Kenya 3
NL - Olanda 3
PY - Paraguay 3
SA - Arabia Saudita 3
AE - Emirati Arabi Uniti 2
AU - Australia 2
CO - Colombia 2
DZ - Algeria 2
ID - Indonesia 2
UZ - Uzbekistan 2
VE - Venezuela 2
AZ - Azerbaigian 1
BB - Barbados 1
BG - Bulgaria 1
CL - Cile 1
CR - Costa Rica 1
EG - Egitto 1
KG - Kirghizistan 1
KR - Corea 1
LU - Lussemburgo 1
LV - Lettonia 1
MA - Marocco 1
MD - Moldavia 1
NG - Nigeria 1
NP - Nepal 1
NZ - Nuova Zelanda 1
PA - Panama 1
PT - Portogallo 1
RS - Serbia 1
TM - Turkmenistan 1
TN - Tunisia 1
Totale 2.620
Città #
Fairfield 170
Chandler 131
Ashburn 125
Singapore 116
Hong Kong 91
Woodbridge 83
Seattle 76
Houston 75
Wilmington 69
Princeton 54
The Dalles 53
Los Angeles 48
Cambridge 46
Jacksonville 43
New York 31
Lauterbourg 30
Helsinki 29
Dublin 27
San Jose 27
Beijing 24
Istanbul 21
Ho Chi Minh City 18
Moscow 17
Ann Arbor 16
Chicago 14
Shanghai 14
Buffalo 13
Council Bluffs 13
San Francisco 13
Redondo Beach 12
Dallas 11
Frankfurt am Main 11
London 11
Santa Clara 11
Phoenix 9
San Diego 9
Warsaw 9
Atlanta 8
Chennai 8
Des Moines 8
Rio de Janeiro 8
Stockholm 8
São Paulo 8
Mexico City 7
Tokyo 7
Poplar 6
Brooklyn 5
Hanoi 5
Toronto 5
Boston 4
Düsseldorf 4
Guangzhou 4
Johannesburg 4
Montreal 4
Orem 4
Amman 3
Amsterdam 3
Ankara 3
Belo Horizonte 3
Brussels 3
Charlotte 3
Dhaka 3
Haiphong 3
Hangzhou 3
Milan 3
Munich 3
Nairobi 3
Portsmouth 3
Querétaro 3
Salvador 3
Aparecida de Goiânia 2
Baghdad 2
Brasília 2
Bắc Ninh 2
Calgary 2
Changsha 2
Chongqing 2
City of London 2
Columbus 2
Da Nang 2
Denver 2
Falkenstein 2
Franca 2
Ilhéus 2
Irecê 2
Kilburn 2
Lahore 2
Manaus 2
Maricá 2
Porto Alegre 2
Quận Bình Thạnh 2
Redwood City 2
Ribeirão Preto 2
Ribeirão das Neves 2
Rome 2
Sabbio Chiese 2
Santa Fe 2
Santo André 2
Shenyang 2
Sorocaba 2
Totale 1.782
Nome #
Should platinum-based chemotherapy be preferred for germline BReast CAncer genes (BRCA) 1 and 2-mutated pancreatic ductal adenocarcinoma (PDAC) patients? A systematic review and meta-analysis 128
Systemic therapies in patients with advanced well-differentiated pancreatic neuroendocrine tumors (PanNETs): When cytoreduction is the aim. A critical review with meta-analysis 127
Pharmacodynamics, clinical findings and approval status of current and emerging tyrosine-kinase inhibitors for pancreatic neuroendocrine tumors 127
Primary hepatic lymphoma in a patient with previous rectal adenocarcinoma: a case report and discussion of etiopathogenesis and diagnostic tools 111
Systemic Chemotherapy for Advanced Rare Pancreatic Histotype Tumors: A Retrospective Multicenter Analysis 110
Dual inhibition of mTOR pathway and VEGF signalling in neuroendocrine neoplasms: from bench to bedside 105
Digital Ischemia in Patients with Solid Tumors: a Case Report and Review of the Literature 101
Predictive Markers of Response to Everolimus and Sunitinib in Neuroendocrine Tumors 98
Adjuvant Treatment for Locally Advanced Rectal Cancer Patients After Preoperative Chemoradiotherapy: When, and for Whom? 97
Evaluation of Biomarkers for the Prediction of Venous Thromboembolism in Ambulatory Cancer Patients 96
The role of multimodal treatment in patients with advanced lung neuroendocrine tumors 95
Oxaliplatin-Based Chemotherapy in Advanced Neuroendocrine Tumors: Clinical Outcomes and Preliminary Correlation with Biological Factors 94
Treatments for colorectal liver metastases: A new focus on a familiar concept 93
Bevacizumab maintenance in metastatic colorectal cancer: How long? 91
HER2/HER3 pathway in biliary tract malignancies; systematic review and meta-analysis: a potential therapeutic target? 91
Cabozantinib in neuroendocrine tumours: tackling drug activity and resistance mechanisms 90
Should cT2N0M0 be managed as a localized or locally advanced esophageal carcinoma? 89
Lung carcinoids with high proliferative activity: Further support for the identification of a new tumor category in the classification of lung neuroendocrine neoplasms 89
Metronomic and metronomic-like therapies in neuroendocrine tumors - Rationale and clinical perspectives 87
The Italian Rare Pancreatic Exocrine Cancer Initiative 87
Basaloid squamous cell carcinoma: a rare tumor at the esophagogastric junction and an unexpected durable complete response to FOLFOX-4 83
Primary prevention of cancer-related thrombosis: special focus on ambulatory patients 79
Preventing Venous Thromboembolism in Ambulatory Cancer Patients: The ONKOTEV Study 75
High-risk human papillomavirus in anal squamous cell carcinoma: A 'conservative' leading role 73
FOLFIRI in patients with locally advanced or metastatic pancreatic or biliary tract carcinoma: a monoinstitutional experience 73
Successful palliative approach with high-intensity focused ultrasound in a patient with metastatic anaplastic pancreatic carcinoma: a case report 71
Systemic therapy beyond first-line in advanced gastric cancer: An overview of the main randomized clinical trials 66
The pandemic within the pandemic: the surge of neuropsychological disorders in Italian children during the COVID-19 era 64
Tumor-to-tumor metastasis: breast cancer metastatic to thymic epithelial tumor 61
Totale 2.651
Categoria #
all - tutte 15.902
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 15.902


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021137 0 0 0 0 0 0 0 0 0 76 27 34
2021/2022178 0 42 3 11 1 9 15 21 13 6 7 50
2022/2023290 27 0 3 50 14 83 1 32 54 0 9 17
2023/2024156 20 3 11 29 1 10 3 10 34 1 4 30
2024/2025452 0 1 1 67 43 51 48 28 37 46 78 52
2025/2026915 99 116 83 188 147 61 103 21 29 68 0 0
Totale 2.651